Sarcomas

Latest News

Line illustration of two bones and connective tissue
OH2 Shows Safety and Anticancer Response with HX008 for Advanced Sarcoma

March 3rd 2025

Preliminary findings suggest that OH2 monotherapy is safe, with promising responses observed when combined with HX008 in locally advanced or metastatic sarcoma.

light blue background with a white outline indicating sarcoma
Pembrolizumab Plus Standard Therapy Improves Outcomes in Stage III Soft Tissue Sarcoma

January 21st 2025

blue background with a white outline indicating bone
GSK’227 Gets FDA Breakthrough Therapy Designation for Advanced Osteosarcoma

January 15th 2025

light blue background with a white outline indicating sarcoma
Adding Pembrolizumab to Preoperative Radiotherapy and Surgery Improves DFS in Sarcoma

January 6th 2025

clinician pointing toward "FDA"
FDA Grants Rare Pediatric Designation to Elraglusib for Ewing Sarcoma

November 15th 2024

Latest CME Events & Activities

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

View More

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

View More

Epithelioid Sarcoma: Applying Clinical Updates to Real Patient Cases

View More

Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma

View More

Mastering Epithelioid Sarcoma: Enhancing Diagnostic Precision and Tailoring Treatment Strategies

View More

Clinical Showcase™: Selecting the Best Next Steps for a Patient with Epithelioid Sarcoma

View More

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes

View More

More News